The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets

Thrombosis Research

Volumn 90, Issue 5, 1998, Pages 207-214

  Suzuki, Hiroshi ^a   Shima, Midori ^a   Kamisue, Seiki ^a   Nakai, Hiroaki ^a   Nogami, Keiji ^a   Shibata, Masaru ^a   Morichika, Shogo ^a   Tanaka, Ichiro ^a   Giddings, John C ^b   Yoshioka, Akira ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Activated platelet; Factor VIII; Phospholipid; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; MEMBRANE PHOSPHOLIPID; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE ACTIVATION;

BINDING SITES; BLOOD PLATELETS; FACTOR VIII; HUMANS; PLATELET ACTIVATION; PROTEIN BINDING; VON WILLEBRAND FACTOR;

EID: 0032102590     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00034-6     Document Type: Article

References (29)

1. 1. Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Rien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN, Tuddenhum EGD, Lawn RM, Capon DJ. Structure of human factor VIII. Nature 1984;312:337-42.
2. 2. Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor Villa in the activation of bovine factor X. J Biol Chem 1981;256:3433-42.
3. 3. Rosing JS, Van Rijn JLML, Bevers EM, Van Dieijen G, Comfurius P, Zwaal, FA. The role of activated human platelets in prothrombin and factor X activation. Blood 1985;65:319-32.
4. 4. Yoshioka A, Peake IR, Furlong BL, Furlong RA, Giddings JC, Bloom AL. The interaction between factor VIII clotting antigen (VIII-CAg) and phospholipid. Br J Haematol 1983; 55:27-36.
5. 5. Gilbert GE, Sims PJ, Wiedmer T, Furie B. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991;266:17261-8.
6. 6. Stern DM, Drillings M, Nossel, HL, Hurler-Jensen A, Lagamma KS, Owen J. Binding of factors IX and IXA to cultured vascular endothelial cells. Proc Natl Acad Sci USA 1983; 80:4119-23.
7. 7. McGee MP. Functional difference between intrinsic and extrinsic coagulation pathways. J Biol Chem 1991;266:8079-85.
8. 8. Hoyer LW. The factor VIII complex: Structure and function. Blood 1981;58:1-13.
9. 9. Kaufman RJ, Wasley LC, Davies MV, Wise RJ, Israel DI, Dorner AJ. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Molec Cell Biol 1989;9:1233-42.
10. 10. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor: Studies on post-transfusion and dissociated factor VIII and in patients with von Willebrand disease. J Clin Invest 1977;60:390-404.
11. 11. Koedam J, Meijers J, Sixma J, Bouma B. Inactivation of human factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988;82:1236-43.
12. 12. Hill-Eubanks DC, Lollar P. Von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 1990;265:17854-8.
13. 13. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/ FVIII interaction. Blood 1990;75:20-6.
14. 14. Arai M, Scandella D, Hoyer LW. Molecular basis of factor VIII inhibition by human anti-bodies. Antibodies that bind to the factor VIII heavy chain prevent the interaction of factor VIII with phospholipid. J Clin Invest 1989; 83:1978-84.
15. 15. Foster PA, Fukcher CA, Houghten RA, Zimmerman TS. Synthetic factor VIII peptides with amino acids sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 1990; 75:1999-2004.
16. 16. Foster P, Fulcher CA, Houghten RA, Zimmerman TS. An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 1988;263:5230-4.
17. 17. Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb Haemost 1993;69: 240-6.
18. 18. Saenko EL, Shima M, Rajalakshmi KJ, Scandella D. A role for the C2 domain of factor VIII in binding to von Willebrand factor. J Biol Chem 1994;269:11601-5.
19. 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 1988;263:16467-70.
20. 20. Gilbert GE, Drinkwater D, Barter S, Clouse SB. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). J Biol Chem 1992;267:15861-8.
21. 21. Nishino M, Nishino S, Sugimoto M, Shibata M, Tsuji S, Yoshioka A. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy. Int J Hematol 1996;64:127-34.
22. 22. Shima M, Yoshioka A, Nakai H, Tanaka I, Sawamoto Y, Kamisue S, Terada S, Fukui H. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor. Int J Hematol 1991;54:515-22.
23. 23. Shima M, Morimoto J, Imai S, Tsubura Y, Yoshioka A, Fukui H. Production and characterization of monoclonal antibodies against von Willebrand factor (vWF). J Nara Med Assoc 1985;36:662-9.
24. 24. Shima M, Yoshioka A, Nakajima M, Nakai H, Fukui H. A monoclonal antibody (NMC-VIII/ 10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells. Br J Haematol 1992;81:533-8.
25. 1689 detected by a novel ELISA. Br J Haematol 1994;86:106-11.
26. 26. Giddings JC, Brookes LR, Piovella F, Bloom AL. Immunological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules. Br J Haematol 1982;52:79-88.
27. 27. Koutts J, Walsh PN, Plow EF, Fenton JW, Bouma BN, Zimmerman TS. Active release of human platelet factor VIII-related antigen by adenosin diphosphate, collagen, and thrombin. J Clin Invest 1978;62:1255-63.
28. 28. George JN, Onofre AR. Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4. Blood 1982;59:194-7.
29. 29. Stenberg PR, Shuman MA, Levine SP, Bainton DF. Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol 1984;98:748-61.